Zonulin in consumer reports usually means a stool or blood ELISA marketed as a barrier permeability marker. Research describes zonulin-family signalling (prehaptoglobin-2 pathway) that can modulate tight junctions, especially in celiac disease models, but independent groups report that widely used commercial ELISAs may not measure the intended protein and correlate poorly with lactulose–mannitol permeability tests (Massier et al., 2021).
Treat a flagged zonulin line as hypothesis-generating at best until the specific assay is validated, not proof of “leaky gut” requiring supplement stacks.
Full mechanism and test tiers: Intestinal barrier dysfunction.
What not to conclude
| Report line | Weak conclusion | Read instead |
|---|---|---|
| High stool zonulin | Confirmed permeability | Barrier page, zonulin section |
| Low zonulin | Barrier proven intact | Assay-specific; not gold-standard permeability |
| High zonulin + low Akkermansia | Automatic barrier protocol | Multi-marker synthesis |
Related pages
- Reading your microbiome report
- Intestinal barrier · Secretory IgA
- Gluten-related disorders
- Gut inflammation markers (distinct question)
- Literature: Massier 2021